Clinical characteristics of patients with SS divided according to the presence of serum anti-RLIP76 IgG immunoreactivity
| Characteristics . | Patients with anti-RLIP76 IgG, n = 11 . | Patients without anti-RLIP76 IgG, n = 54 . |
|---|---|---|
| Median age, y (range) | 57 (47-65) | 52 (20-77) |
| Sex, M/F | 1/10 | 4/50 |
| Median disease duration, y (range) | 6.5 (1-19) | 6 (0.9-30) |
| Median erythrocyte sedimentation rate, | 16 (10-30) | 16 (2-64) |
| mm/hr (range) | ||
| Median C-reactive protein, mg/L (range) | 3 (0-72) | 3 (0-48) |
| Median C3 (range) | 144 (72-179) | 113 (69-286) |
| Median C4 (range) | 22 (11-51) | 22 (14-46) |
| Lung fibrosis, % | 54.5 | 33.3 |
| Median skin score (range)* | 13 (4-30) | 8 (4-27) |
| Characteristics . | Patients with anti-RLIP76 IgG, n = 11 . | Patients without anti-RLIP76 IgG, n = 54 . |
|---|---|---|
| Median age, y (range) | 57 (47-65) | 52 (20-77) |
| Sex, M/F | 1/10 | 4/50 |
| Median disease duration, y (range) | 6.5 (1-19) | 6 (0.9-30) |
| Median erythrocyte sedimentation rate, | 16 (10-30) | 16 (2-64) |
| mm/hr (range) | ||
| Median C-reactive protein, mg/L (range) | 3 (0-72) | 3 (0-48) |
| Median C3 (range) | 144 (72-179) | 113 (69-286) |
| Median C4 (range) | 22 (11-51) | 22 (14-46) |
| Lung fibrosis, % | 54.5 | 33.3 |
| Median skin score (range)* | 13 (4-30) | 8 (4-27) |
P > .05 for all characteristics.
Skin score is the assessment of skin thickening.